Stay updated on APL-2 in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.

Latest updates to the APL-2 in Neovascular AMD Clinical Trial page
- Check7 days agoChange DetectedA banner announces NIH website updates and says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence,” with both terms appearing during the transition.SummaryDifference1%

- Check14 days agoChange DetectedThe site footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0 on the 403 error page.SummaryDifference0.2%

- Check42 days agoChange DetectedThe page now shows a 403 Forbidden error, indicating the study record is temporarily inaccessible. The standard page chrome (header/footer) remains visible while the main content is unavailable.SummaryDifference17%

- Check63 days agoChange DetectedThe revision label in the page footer was updated from v3.6.5 to v3.6.6, reflecting a small version update to the site frontend. No study details or user-facing content were changed.SummaryDifference0.1%

- Check84 days agoChange DetectedThe footer revision label changed from Revision: v3.6.4 to Revision: v3.6.5, indicating a minor site update that does not modify study details.SummaryDifference0.1%

Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.